FY Roadshow - Global
Skip to main content
Ipsen Home Page
Press shift tab to select search category

Loading...
  • Newsroom arrow down
      < Back
    • Newsroom
    • Press Releases
    • Media Updates
    • Media Library
    • Contacts
    • Subscribe
  • Investors arrow down
      < Back
    • Investors
    • Investors
    • Financial Results
    • Annual Reports & Accounts
    • Investor Events
    • Financial Calendar
    • Corporate News
    • Regulated Information
    • Shareholder Information
    • Contacts
    • Subscribe
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Culture
    • Job Search
  • Contacts arrow down
      < Back
    • Contacts
    • Contacts
    • Our Locations
    • Report Side Effects
    • Subscribe
  • Press shift tab to select search category

    Loading...
  • English  EN     Français  FR     EN  arrow_down
    • English EN
    • Français FR
  • Global Global
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • Middle East & Africa
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Switzerland
    • Austria
    • UAE & Gulf
  • Home
  • Company
      < Back
    • Company
    • Company
    • Leadership
    • History
    • Fondation Ipsen
  • Expertise
      < Back
    • Expertise
    • Oncology
    • Rare Disease
    • Neuroscience
    • Medicines
  • Science
      < Back
    • Science
    • Science
        < Back
      • Science
      • Oncology
      • Rare Disease
      • Neuroscience
    • Profiles
    • Partnering
        < Back
      • Partnering
      • Therapeutic focus
      • Meet the team
    • Clinical Trials
        < Back
      • Clinical Trials
      • Lay Summaries
      • Find Clinical Trials
    • Pipeline
  • Sustainability
      < Back
    • Sustainability
    • Sustainability
    • Environment
    • Patients
    • People
    • Governance
    • Our Standards
  • Patients
      < Back
    • Patients
    • Patients
    • Together for Oncology
    • Together for Rare Disease
    • Together for Neuroscience
    • Collaborate with us
  • Stories
  1. Home
  2. Events
  3. Roadshows events

FY Roadshow

Post navigation

Previous
Next

FY Roadshow

Speakers

David Loew

David Loew

Chief Executive Officer

Aymeric Le Chatelier

Aymeric Le Chatelier

Executive Vice President

Chief Financial Officer

FY Roadshow

- 02 March 2026 - 0 mins read

Speakers

David Loew

David Loew

Chief Executive Officer

Aymeric Le Chatelier

Aymeric Le Chatelier

Executive Vice President

Chief Financial Officer

Post navigation

Previous
Next
Share this on social media
  • Share on LinkedIn
  • Share on Facebook

Related Events

Roadshow Paris
01 September 2025 0 mins read

Roadshow Paris

Roadshow UK
02 September 2025 0 mins read

Roadshow UK

Oddo BHF Lyon Forum
09 January 2025 0 mins read

Oddo BHF Lyon Forum

CIC Forum by Market Solutions
20 November 2024 0 mins read

CIC Forum by Market Solutions

Investor roadshow, Paris (with management)
09 September 2024 0 mins read

Investor roadshow, Paris (with management)

Investor roadshow, Frankfurt
23 May 2024 0 mins read

Investor roadshow, Frankfurt

Investor roadshow, Zurich
21 May 2024 0 mins read

Investor roadshow, Zurich

Non-deal investor roadshow, Paris
27 February 2024 0 mins read

Non-deal investor roadshow, Paris

Non-deal investor roadshow, New York
22 February 2024 0 mins read

Non-deal investor roadshow, New York

Non-deal investor roadshow, Boston
21 February 2024 0 mins read

Non-deal investor roadshow, Boston

IPN price

€126.10

 €1.10 (0.88%)

  • Media Library
  • Annual Report
  • Contacts
  • Our Locations

Ipsen logo
LinkedIn Instagram Facebook Youtube
  • Terms and Conditions
  • Cookie Policy
  • Global Privacy Policy

© Ipsen Pharma. All rights reserved - 2025

You are now leaving the Ipsen group website. To continue, please click on Continue?

Continue